查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1916903

静脉输液袋市场按溶液配方、溶液类型、给药方法、包装材料、最终用户、应用和分销管道划分－2026-2032年全球预测

Intravenous Fluid Bags Market by Fluid Composition, Fluid Type, Administration Mode, Packaging Material, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，静脉输液袋市场价值将达到 13.4 亿美元，到 2026 年将成长至 14.2 亿美元，到 2032 年将达到 21 亿美元，年复合成长率为 6.68%。

关键市场统计数据
基准年 2025 13.4亿美元
预计年份：2026年 14.2亿美元
预测年份 2032 21亿美元
复合年增长率 (%) 6.68%

全面介绍输液袋，概述其临床适应症、製造材料、监管压力、供应链趋势以及在各种环境下的使用趋势

静脉输液袋仍然是现代临床照护的重要组成部分，可在各种情况下用于补充液体、復苏、给药和营养支持。临床医生期望这些产品性能稳定可靠，而供应链和采购团队则需要清楚了解材料成分、包装和通路，以确保供应不间断。在此背景下，製造商需要在临床疗效、不断变化的监管要求和环境因素之间寻求平衡，从而推动材料选择和生产方法的变革。

对重塑静脉输液袋设计、采购、临床通讯协定、环境优先事项和数位化库存管理实践的转型转变进行策略评估

输液袋领域正经历多项变革，这些变革影响着输液袋的设计、采购和临床应用。首先，日益严格的监管审查和品质要求促使供应商改进聚合物的选择和灭菌工艺，同时提高批次间的可追溯性和序列化程度。这些措施在急诊和分散式医疗环境中都变得愈发重要，因为在这些环境中，产品性能的一致性至关重要。

对 2025 年美国关税对供应链韧性、成本结构、采购决策和监管合规压力的累积影响进行重点分析。

2025年美国关税政策对输液袋生态系内的成本结构、筹资策略和供应商关係产生了连锁反应。进口聚合物、组件和成品的关税相关课税增加了买家的进口成本，迫使采购部门重新评估供应商所在地，并在条件允许的情况下加快近岸外包和供应商多元化策略。为此，一些製造商正在重新分配生产，优先发展国内或区域生产线，以降低进口关税和地缘政治风险的影响。

可操作的細項分析揭示了输液製剂、类型、给药方法和包装材料的产品创新、临床应用模式、分销管道趋势和最终用户优先事项

市场区隔反映了静脉输液袋市场中不同的产品、终端用户和包装动态，这些动态驱动着临床选择和商业策略，每种情况都需要量身定制的方法。根据液体成分，相关人员评估胶体溶液和晶体溶液。胶体溶液进一步分为白蛋白溶液、聚葡萄糖、明胶溶液和淀粉溶液，而晶体溶液则分为平衡溶液和生理食盐水。每种溶液都具有特定的血液动力学和电解质管理特性，从而影响医院的处方集和手术全期通讯协定。根据液体类型，市场涵盖葡萄糖溶液、乳酸林格氏液和氯化钠溶液，这些溶液的选择取决于临床适应症，例如渗透压管理、电解质补充和维持治疗。

区域洞察提供了对美洲、欧洲、中东、非洲和亚太地区的需求驱动因素、采购政策、製造地和治疗模式的全面分析。

区域趋势正在以不同的方式影响着各主要地区静脉输液袋的采购、监管和生产策略。在美洲，采购流程较为复杂，私立医院网路和大规模综合医疗系统对供应商的选择起着重要作用。能够展现品管系统、灵活物流和永续性承诺的供应商往往更容易被选中。美洲地区同时存在公共采购和私人合同，这就需要灵活的商业模式。

提供领先的输液袋製造商和供应商的竞争情报，概述其企业策略、生产能力、伙伴关係模式、产品差异化和关键成长因素。

输液袋领域的主要企业正透过产品研发、产能扩张和合作等多种策略来应对临床和供应方面的挑战。领先的製造商正加大对材料科学的投入，以拓展其非PVC产品线，从而在满足输液药物稳定性要求的同时，降低对环境的影响。这些投资与产能策略相辅相成，重点在于法规遵循、製程检验，以及在贸易或原材料供应中断的情况下快速找到合适的替代聚合物供应商。

切实可行的、优先考虑的建议，旨在加强供应链，促进永续包装的采用，优化临床利用，并创建新的分销和服务模式。

产业领导者应优先采取一系列具体行动，以增强静脉输液袋产品线的韧性，提升临床疗效，并促进永续性。首先，应实现製造地多元化，并投资于合格的二级供应商，以降低单一来源依赖的风险，并在贸易或原材料供应出现波动时迅速调配生产。同时，应加快材料转型计划，评估非聚氯乙烯（PVC）聚合物的生命週期优势，并严格检验临床适用性和灭菌效果。

对调查方法、资料来源、检验过程、相关人员访谈以及用于确保对市场进行严谨理解的分析框架进行透明的描述。

本分析所依据的研究采用了混合方法，整合了与主要相关人员的对话、二手文献综述和定性检验，以确保研究结果的严谨性和平衡性。关键投入包括与临床医生、采购负责人、监管专家和供应链经理进行结构化访谈，以收集有关产品性能、采购挑战和临床偏好的实际见解。这些访谈，以及与製造商和经销商的针对性对话，有助于了解生产能力、材料选择和物流限制。

总结全文，为製造商、医疗保健系统、经销商和政策制定者提供明确的策略启示。明确近期和结构性行动的优先事项。

总之，输液袋市场正处于转折点，临床需求、监管预期、永续性压力和贸易趋势的交汇正在重塑产品设计和供应策略。积极推动材料转换、实现製造地多元化并加强经销伙伴的相关人员，将更有利于确保临床供应的连续性，同时满足环境和监管要求。临床应用模式和给药偏好进一步凸显了设备相容性和标籤清晰度在采购决策中的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依输液成分分類的静脉输液袋市场

  • 胶体製剂
    • 白蛋白
    • 聚葡萄糖
    • 明胶
    • 淀粉
  • 晶体溶液
    • 平衡液体
    • 生理食盐水

9. 依输液类型分類的静脉输液袋市场

  • 葡萄糖溶液
  • 林格氏乳酸盐溶液
  • 氯化钠溶液

10. 依给药方式分類的静脉输液袋市场

  • 重力输液
  • 点滴帮浦
  • 注射式帮浦

第十一章 依包装材料分類的静脉输液袋市场

  • 不含聚氯乙烯
    • 乙烯-醋酸乙烯酯
    • 聚烯
  • PVC

第十二章 依最终用户分類的静脉输液袋市场

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院
    • 私立医院
    • 公立医院

第十三章 依应用分類的静脉输液袋市场

  • 紧急医疗护理
  • 预防医学
  • 外科手术
  • 治疗护理

14. 按通路分類的静脉输液袋市场

  • 直销
  • 医院药房
  • 网路药房
  • 零售药房

15. 按地区分類的静脉输液袋市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 静脉输液袋市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各国静脉输液袋市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章美国静脉输液袋市场

第十九章：中国静脉输液袋市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Grifols, SA
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • Nipro Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Terumo Corporation
Product Code: MRR-AE420CB153E3

The Intravenous Fluid Bags Market was valued at USD 1.34 billion in 2025 and is projected to grow to USD 1.42 billion in 2026, with a CAGR of 6.68%, reaching USD 2.10 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.34 billion
Estimated Year [2026] USD 1.42 billion
Forecast Year [2032] USD 2.10 billion
CAGR (%) 6.68%

An integrated introduction to intravenous fluid bags that outlines clinical indications, manufacturing materials, regulatory pressures, supply chain dynamics, and cross-setting utilization trends

Intravenous fluid bags remain a foundational element of modern clinical care, enabling hydration, resuscitation, medication delivery and nutritional support across a diverse set of settings. Clinicians depend on predictable performance from these products, while supply chain and procurement teams require clarity on material composition, packaging formats and distribution pathways to ensure uninterrupted availability. Against this backdrop, manufacturers are balancing clinical efficacy with evolving regulatory expectations and environmental considerations, prompting shifts in material choices and manufacturing practices.

As clinical protocols evolve, the role of fluid selection-ranging from isotonic crystalloids to colloid solutions-intersects with rising attention to compatibility with infusion systems, biocompatibility of packaging materials and infection prevention standards. At the same time, health systems and ambulatory providers are re-evaluating inventory strategies to minimize waste and ensure rapid access during surges. This requires an integrated approach that connects product design, supplier networks and end-user workflows.

Consequently, stakeholders must reconcile clinical preferences with logistical constraints and sustainability objectives. The introduction outlines these converging pressures and frames the subsequent sections, which examine technological, regulatory and commercial dynamics that will shape how intravenous fluid bags are produced, procured and used in the near term and beyond.

A strategic assessment of transformative shifts reshaping intravenous fluid bag design, sourcing, clinical protocols, environmental priorities and digital-enabled inventory management practices

The landscape for intravenous fluid bags is undergoing several transformative shifts that affect design, sourcing and clinical deployment. First, regulatory scrutiny and quality expectations are prompting suppliers to refine polymer selection and sterilization processes while improving traceability and serialization across batches. These measures are increasingly important for both acute care environments and decentralized settings, where consistent product performance is essential.

Second, sustainability considerations are influencing material innovation and packaging strategies. Innovations such as reduced-PVC solutions and alternative polymers are being evaluated not only for their environmental benefits but also for compatibility with existing infusion devices and sterilization regimes. This parallel focus on clinical compatibility and lifecycle impact is reshaping procurement criteria and supplier conversations.

Third, digital enablement of inventory and procurement functions is accelerating adoption of connected supply chain practices. Providers are piloting inventory telemetry and electronic procurement integrations to reduce expiries and improve replenishment speed, thereby altering how manufacturers package and ship products. Finally, clinical practice evolution-driven by evidence on fluid choice, perioperative management and outpatient infusion programs-is changing demand patterns across settings. Taken together, these shifts require integrated responses from manufacturers, distributors and clinical leaders to optimize product portfolios and delivery models.

A focused analysis of the cumulative impacts of United States tariffs in 2025 on supply chain resilience, cost structures, sourcing decisions and regulatory compliance pressures

The imposition of tariffs in the United States in 2025 has had a cascading effect on cost structures, sourcing strategies and supplier relationships within the intravenous fluid bag ecosystem. Tariff-related duties on imported polymers, components and finished goods have increased landed costs for purchasers, prompting procurement teams to reassess supplier footprints and to accelerate nearshoring and supplier diversification strategies where feasible. In response, some manufacturers have revisited production allocation, prioritizing domestic or regional manufacturing lines to mitigate exposure to import duties and geopolitical risks.

Consequently, distributors and health systems have had to adapt contractual terms and inventory policies to absorb price volatility while maintaining clinical continuity. Many stakeholders have sought longer-term supply agreements and collaborative risk-sharing arrangements to stabilize access and support capital investments in domestic manufacturing capacity. At the same time, tariff pressure has elevated the importance of cost-to-serve analyses and lifecycle assessments when comparing alternative packaging materials, since higher import costs alter the relative economics of PVC versus non-PVC solutions and may accelerate migration toward locally produced options.

Regulatory compatibility and quality assurance remain non-negotiable, so any shift in sourcing must be accompanied by accelerated validation, supplier audits and clear change-management communications to clinical teams. Ultimately, the 2025 tariff changes have underscored the need for agility in sourcing, a premium on manufacturing flexibility and the strategic value of multi-sourced supply chains that can sustain patient care under shifting trade conditions.

Actionable segmentation insights revealing product innovation, clinical adoption patterns, channel behaviors and end-user priorities across fluid composition, types, administration and packaging materials

Segmentation drives both clinical choices and commercial strategy in the intravenous fluid bag market, reflecting distinct product, end-user and packaging dynamics that require tailored approaches. Based on fluid composition, stakeholders evaluate Colloids versus Crystalloids, with Colloids further differentiated by Albumin, Dextrans, Gelatins and Starches and Crystalloids separated into Balanced Solutions and Normal Saline, each offering particular hemodynamic and electrolyte management characteristics that influence hospital formularies and perioperative protocols. Based on fluid type, the market encompasses Dextrose Solution, Ringer's Lactate Solution and Sodium Chloride Solution, which are selected according to clinical indications such as osmolarity management, electrolyte replacement and maintenance therapy.

Based on end user, demand patterns differ markedly across Ambulatory Surgical Centers, Clinics, Home Care and Hospitals, with hospitals further distinguished into Private Hospitals and Public Hospitals, each segment presenting unique procurement cycles, contract structures and usage intensities. Based on administration mode, gravity infusion remains prevalent in low-acuity settings while Infusion Pumps and Syringe Pumps dominate controlled infusion scenarios, influencing compatibility and labeling requirements. Based on packaging material, products are classified as Non-PVC and PVC, with Non-PVC options including Ethylene Vinyl Acetate and Polyolefin; material choice affects shelf life, environmental footprint and device compatibility.

Based on application, use cases span Emergency Care, Preventive Care, Surgical Procedures and Therapeutic Care, which drive formulation preferences and packing volumes. Based on distribution channel, Direct Sales, Hospital Pharmacy, Online Pharmacy and Retail Pharmacy each present different margins, service expectations and regulatory touchpoints. These segmentation layers interact to create differentiated product lifecycles and commercialization pathways that manufacturers and providers must navigate deliberately.

Regional insights synthesizing demand drivers, procurement policies, manufacturing footprints and treatment patterns across the Americas, Europe Middle East & Africa and Asia-Pacific

Regional dynamics shape procurement, regulation and manufacturing strategies for intravenous fluid bags in distinct ways across major geographies. In the Americas, procurement sophistication is high and private hospital networks and large integrated delivery systems exert influence over supplier selection, often favoring suppliers who can demonstrate quality systems, responsive logistics and sustainability credentials. The Americas region also includes a combination of public procurement agendas and private contracting that requires flexible commercial models.

In Europe, Middle East & Africa, regulatory frameworks and reimbursement models vary widely; European regulatory rigor coexists with emerging-market needs in parts of the Middle East and Africa where distribution complexity and cold chain considerations can be pronounced. These differences necessitate adaptable packaging and labeling strategies, as well as tailored commercial approaches for public tenders and private purchasers. In Asia-Pacific, a mix of large public health systems, expanding private care delivery and robust manufacturing ecosystems influences both demand and supply. Asia-Pacific manufacturers have increasingly integrated into global supply chains, offering scale and cost efficiencies while local regulatory pathways are evolving to emphasize product safety and environmental considerations.

Understanding these regional nuances enables manufacturers and distributors to prioritize investments in localized manufacturing, regulatory dossiers and channel partnerships that align with regional procurement realities and clinical practice patterns.

Competitive intelligence summarizing company strategies, manufacturing capabilities, partnership models, product differentiation and growth levers among leading intravenous fluid bag manufacturers and suppliers

Key companies in the intravenous fluid bag sector are pursuing a mix of product development, capacity expansion and partnership strategies to address clinical and supply-side priorities. Leading manufacturers are investing in material science to expand non-PVC offerings that reduce environmental impact while ensuring compatibility with infusible drug stability requirements. These investments are coupled with production capacity strategies that emphasize regulatory compliance, process validation and the ability to qualify alternative polymer suppliers rapidly when trade or raw material disruptions occur.

At the same time, several firms are augmenting their value proposition through service-oriented offerings, such as integrated logistics, inventory management tools and clinical education programs that help downstream purchasers optimize utilization and reduce waste. Strategic alliances and targeted acquisitions are being used to acquire specialty formulations, regional distribution networks and infusion device compatibility expertise. Firms that combine robust quality management systems with flexible production footprints and an emphasis on sustainability reporting are better positioned to meet increasing procurement and regulatory expectations.

Competitive differentiation also stems from the ability to support complex commercial models-such as consignment, outcome-based contracting and bundled supply agreements-that align incentives across providers and suppliers. As stakeholders demand greater transparency on supply chain resilience and product provenance, companies that can demonstrate end-to-end control and rapid response capabilities will secure stronger commercial positions.

Practical and prioritized recommendations to strengthen supply chains, accelerate sustainable packaging adoption, optimize clinical utilization and unlock new distribution and service models

Industry leaders should prioritize a set of concrete actions to strengthen resilience, support clinical outcomes and advance sustainability across their intravenous fluid bag portfolios. First, invest in diversified manufacturing footprints and validated secondary suppliers to reduce single-source vulnerability and to enable rapid allocation of production in response to trade or raw material shocks. Simultaneously, accelerate material transition programs that evaluate non-PVC polymers for lifecycle benefits while rigorously validating clinical compatibility and sterilization outcomes.

Second, collaborate with major health system customers to implement inventory visibility tools and integrated replenishment models that reduce expiration-related waste and improve fill rates during demand surges. These collaborations can be extended to design pooled procurement or consignment arrangements that align incentives and distribute risk. Third, enhance product differentiation through labeling that facilitates safe use with common infusion devices and by offering clinician education modules that support evidence-based fluid selection and administration practices.

Finally, embed sustainability and regulatory readiness into product roadmaps by prioritizing polymers with lower environmental impact, improving packaging efficiency and maintaining proactive regulatory dossiers for rapid market entry. By sequencing these actions-starting with supply base resilience, followed by validated material transitions, integrated distribution solutions and clinician-focused support-leaders can deliver both near-term stability and medium-term competitive advantage.

A transparent description of research methodology, data sources, validation processes, stakeholder interviews and analytical frameworks used to ensure rigorous market understanding

The research underpinning this analysis applies a mixed-methods approach that integrates primary stakeholder engagement, secondary literature review and qualitative validation to ensure rigorous and balanced findings. Primary inputs included structured interviews with clinicians, procurement professionals, regulatory experts and supply chain managers to capture practical insights on product performance, sourcing challenges and clinical preferences. These interviews were complemented by targeted manufacturer and distributor dialogues to understand production capabilities, material choices and logistical constraints.

Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents and industry technical standards that informed interpretations of material compatibility, sterilization methods and administration device interoperability. Where possible, publicly available regulatory filings and device registries were reviewed to validate claims about manufacturing locations and quality systems. Analytical frameworks included value-chain mapping, risk assessment matrices and scenario analysis to highlight vulnerabilities and stress-test potential responses to trade or demand disruptions.

Validation workshops with domain experts were used to reconcile divergent perspectives and to refine recommendations. Throughout the research process, emphasis was placed on traceability of claims and clarity of assumptions, ensuring that conclusions are anchored in observable practices and stakeholder testimony rather than speculative projections.

Conclusive synthesis articulating strategic implications for manufacturers, health systems, distributors and policymakers with clear priorities for near-term and structural actions

In conclusion, the intravenous fluid bag environment is at an inflection point where clinical requirements, regulatory expectations, sustainability pressures and trade dynamics intersect to reshape product design and supply strategies. Stakeholders that proactively address material transitions, diversify manufacturing footprints and strengthen distribution partnerships will be better positioned to ensure uninterrupted clinical supply while responding to environmental and regulatory imperatives. Clinical adoption patterns and administration mode preferences further underscore the importance of device compatibility and labeling clarity as differentiators in procurement decisions.

Moreover, the tariff environment and regional procurement variations have amplified the value of supply chain transparency and flexible contractual arrangements. Providers and manufacturers alike must collaborate more closely on inventory models and clinical education to optimize utilization and reduce waste. Finally, companies that can marry robust quality systems with sustainability credentials and service-oriented commercial models will create defensible positions that address both payer and provider priorities.

This synthesis highlights clear priorities for near-term operational adjustments and medium-term strategic investments that together will shape competitive outcomes and clinical reliability across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Fluid Bags Market, by Fluid Composition

  • 8.1. Colloids
    • 8.1.1. Albumin
    • 8.1.2. Dextrans
    • 8.1.3. Gelatins
    • 8.1.4. Starches
  • 8.2. Crystalloids
    • 8.2.1. Balanced Solutions
    • 8.2.2. Normal Saline

9. Intravenous Fluid Bags Market, by Fluid Type

  • 9.1. Dextrose Solution
  • 9.2. Ringer's Lactate Solution
  • 9.3. Sodium Chloride Solution

10. Intravenous Fluid Bags Market, by Administration Mode

  • 10.1. Gravity Infusion
  • 10.2. Infusion Pump
  • 10.3. Syringe Pump

11. Intravenous Fluid Bags Market, by Packaging Material

  • 11.1. Non-PVC
    • 11.1.1. Ethylene Vinyl Acetate
    • 11.1.2. Polyolefin
  • 11.2. PVC

12. Intravenous Fluid Bags Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Home Care
  • 12.4. Hospitals
    • 12.4.1. Private Hospitals
    • 12.4.2. Public Hospitals

13. Intravenous Fluid Bags Market, by Application

  • 13.1. Emergency Care
  • 13.2. Preventive Care
  • 13.3. Surgical Procedures
  • 13.4. Therapeutic Care

14. Intravenous Fluid Bags Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Hospital Pharmacy
  • 14.3. Online Pharmacy
  • 14.4. Retail Pharmacy

15. Intravenous Fluid Bags Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Intravenous Fluid Bags Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Intravenous Fluid Bags Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Intravenous Fluid Bags Market

19. China Intravenous Fluid Bags Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. B. Braun Melsungen AG
  • 20.6. Baxter International, Inc.
  • 20.7. Fresenius Kabi AG
  • 20.8. Grifols, S.A.
  • 20.9. Hikma Pharmaceuticals PLC
  • 20.10. ICU Medical, Inc.
  • 20.11. Nipro Corporation
  • 20.12. Otsuka Pharmaceutical Co., Ltd.
  • 20.13. Pfizer Inc.
  • 20.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS FLUID BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS FLUID BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTRANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTRANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTRANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GELATINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GELATINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GELATINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY STARCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY STARCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY STARCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY BALANCED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NORMAL SALINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTROSE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTROSE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DEXTROSE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RINGER'S LACTATE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RINGER'S LACTATE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RINGER'S LACTATE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SODIUM CHLORIDE SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SODIUM CHLORIDE SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SODIUM CHLORIDE SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GRAVITY INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GRAVITY INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GRAVITY INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY INFUSION PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY EMERGENCY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY EMERGENCY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY EMERGENCY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PREVENTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PREVENTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY PREVENTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY THERAPEUTIC CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY THERAPEUTIC CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY THERAPEUTIC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 227. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 229. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 257. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 262. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 263. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 269. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 275. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. NATO INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL INTRAVENOUS FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY COLLOIDS, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY CRYSTALLOIDS, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY FLUID TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY ADMINISTRATION MODE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY PACKAGING MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY NON-PVC, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA INTRAVENOUS FLUID BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)